Terms: = Pancreatic cancer AND MEN1, ENSG00000133895, 4221 AND Staging
19 results:
1. pancreatic imaging in men1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
[TBL] [Abstract] [Full Text] [Related]
2. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
3. The Impact of
Cuthbertson DJ; Barriuso J; Lamarca A; Manoharan P; Westwood T; Jaffa M; Fenwick SW; Nuttall C; Lalloo F; Prachalias A; Pizanias M; Wieshmann H; McNamara MG; Hubner R; Srirajaskanthan R; Vivian G; Ramage J; Weickert MO; Pritchard DM; Vinjamuri S; Valle J; Yip VS
Front Endocrinol (Lausanne); 2021; 12():654975. PubMed ID: 34163434
[TBL] [Abstract] [Full Text] [Related]
4. pancreatic Gastrinoma, Gastrointestinal Stromal Tumor (GIST), Pheochromocytoma, and Hürthle Cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case Report and Literature Review.
Arif AA; Kim PTW; Melck A; Churg A; Schwartz Z; Stuart HC
Am J Case Rep; 2021 Jan; 22():e927761. PubMed ID: 33452231
[TBL] [Abstract] [Full Text] [Related]
5. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract] [Full Text] [Related]
6. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract] [Full Text] [Related]
7. pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions.
Worth PJ; Leal J; Ding Q; Trickey A; Dua MM; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinavasa S; Ielpo B; Vicente Lopez E; Lawrence B; Visser BC;
HPB (Oxford); 2020 Sep; 22(9):1359-1367. PubMed ID: 32081540
[TBL] [Abstract] [Full Text] [Related]
8. pancreatic NEUROENDOCRINE TUMORS: SURGICAL RESECTION.
Belotto M; Crouzillard BDNS; Araujo KO; Peixoto RD
Arq Bras Cir Dig; 2019 Feb; 32(1):e1428. PubMed ID: 30758476
[TBL] [Abstract] [Full Text] [Related]
9. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract] [Full Text] [Related]
10. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
11. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract] [Full Text] [Related]
12. Role of endoscopy in the management of gastroenteropancreatic neuroendocrine tumours.
De Angelis C; Pellicano R; Rizzetto M; Repici A
Minerva Gastroenterol Dietol; 2011 Jun; 57(2):129-37. PubMed ID: 21587152
[TBL] [Abstract] [Full Text] [Related]
13. Endocrine neoplasms of the pancreas: pathologic and genetic features.
Capelli P; Martignoni G; Pedica F; Falconi M; Antonello D; Malpeli G; Scarpa A
Arch Pathol Lab Med; 2009 Mar; 133(3):350-64. PubMed ID: 19260741
[TBL] [Abstract] [Full Text] [Related]
14. 50-year appraisal of gastrinoma: recommendations for staging and treatment.
Ellison EC; Sparks J; Verducci JS; Johnson JA; Muscarella P; Bloomston M; Melvin WS
J Am Coll Surg; 2006 Jun; 202(6):897-905. PubMed ID: 16735203
[TBL] [Abstract] [Full Text] [Related]
15. Prospective evaluation of imaging procedures for the detection of pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Langer P; Kann PH; Fendrich V; Richter G; Diehl S; Rothmund M; Bartsch DK
World J Surg; 2004 Dec; 28(12):1317-22. PubMed ID: 15517479
[TBL] [Abstract] [Full Text] [Related]
16. Unusual functioning endocrine tumors.
Raut CP; Lee JE
Curr Treat Options Oncol; 2004 Aug; 5(4):327-34. PubMed ID: 15233909
[TBL] [Abstract] [Full Text] [Related]
17. Interest of Chromogranin A for diagnosis and follow-up of endocrine tumours.
Nehar D; Lombard-Bohas C; Olivieri S; Claustrat B; Chayvialle JA; Penes MC; Sassolas G; Borson-Chazot F
Clin Endocrinol (Oxf); 2004 May; 60(5):644-52. PubMed ID: 15104570
[TBL] [Abstract] [Full Text] [Related]
18. MEN 1 and 2: the role of diagnostic imaging.
Gollini P; Cataldi A; Fava C
Radiol Med; 2004; 107(1-2):78-87. PubMed ID: 15031699
[TBL] [Abstract] [Full Text] [Related]
19. Endocrine tumours of the pancreas: review and recent advances.
Mullan MH; Gauger PG; Thompson NW
ANZ J Surg; 2001 Aug; 71(8):475-82. PubMed ID: 11504292
[TBL] [Abstract] [Full Text] [Related]
